LENZ Therapeutics, Inc. (LENZ) NASDAQ

22.94

-5.115(-18.24%)

Updated at November 05 01:31PM

Currency In USD

Valuation

Market Cap614.38M
Enterprise Value595.61M
P/E Ratio-12.72
PEG Ratio1.73
Price/Sales Ratio133.6
Price/Book Ratio3.23
Enterprise/Revenue126.39
Enterprise/EBITDA-10.35

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-10.34
Operating Margin-12.23

Management Effectiveness

Return On Assets-0.24
Return On Equity-0.26

Income Statement

Revenue0
Revenue/Share0.18
Gross Profit-58,000
EBITDA-49.71M
Net Income-49.77M
Diluted EPS-2.34

Balance Sheet

Total Cash209.52M
Total Cash/Share7.46
Total Debt1.05M
Total Debt/Equity0.01
Current Ratio20.54
Book Value Per Share7.35

Price History

52-Week Change-17.17
52-Week High50.4
52-Week Low16.54
Moving Average 50 Days39.32
Moving Average 200 Days30.95

Statistics

Average Volume801,250
Shares Outstanding28.52M
% Held by Institutions88.06

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:7
Last Split DateMarch 22, 2024